(1)連結財政状態計算書
|
(単位:百万円)
|
|
|
|
前連結会計年度 (2025年3月31日)
|
|
当連結会計年度 (2026年3月31日)
|
|
資産
|
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び現金同等物
|
|
209,838
|
|
208,589
|
|
営業債権及びその他の債権
|
|
593,836
|
|
608,670
|
|
その他の金融資産
|
|
45,015
|
|
47,551
|
|
棚卸資産
|
|
625,243
|
|
595,471
|
|
その他の流動資産
|
|
49,993
|
|
47,429
|
|
小計
|
|
1,523,925
|
|
1,507,710
|
|
売却目的で保有する資産
|
|
59,209
|
|
-
|
|
流動資産合計
|
|
1,583,134
|
|
1,507,710
|
|
非流動資産
|
|
|
|
|
|
有形固定資産
|
|
759,266
|
|
770,688
|
|
のれん
|
|
257,811
|
|
275,711
|
|
無形資産
|
|
239,319
|
|
225,334
|
|
持分法で会計処理されている 投資
|
|
287,977
|
|
203,862
|
|
その他の金融資産
|
|
177,405
|
|
301,222
|
|
退職給付に係る資産
|
|
72,618
|
|
52,222
|
|
繰延税金資産
|
|
34,608
|
|
39,227
|
|
その他の非流動資産
|
|
27,646
|
|
29,065
|
|
非流動資産合計
|
|
1,856,650
|
|
1,897,331
|
|
資産合計
|
|
3,439,784
|
|
3,405,041
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
前連結会計年度 (2025年3月31日)
|
|
当連結会計年度 (2026年3月31日)
|
|
負債及び資本
|
|
|
|
|
|
負債
|
|
|
|
|
|
流動負債
|
|
|
|
|
|
社債及び借入金
|
|
252,892
|
|
241,422
|
|
営業債務及びその他の債務
|
|
488,132
|
|
464,422
|
|
その他の金融負債
|
|
81,364
|
|
63,737
|
|
未払法人所得税等
|
|
10,627
|
|
7,022
|
|
引当金
|
|
89,711
|
|
110,408
|
|
その他の流動負債
|
|
109,360
|
|
114,335
|
|
小計
|
|
1,032,086
|
|
1,001,346
|
|
売却目的で保有する資産に 直接関連する負債
|
|
6,661
|
|
-
|
|
流動負債合計
|
|
1,038,747
|
|
1,001,346
|
|
非流動負債
|
|
|
|
|
|
社債及び借入金
|
|
1,033,236
|
|
910,033
|
|
その他の金融負債
|
|
91,157
|
|
87,885
|
|
退職給付に係る負債
|
|
24,841
|
|
22,084
|
|
引当金
|
|
25,974
|
|
26,383
|
|
繰延税金負債
|
|
111,048
|
|
78,321
|
|
その他の非流動負債
|
|
40,366
|
|
42,316
|
|
非流動負債合計
|
|
1,326,622
|
|
1,167,022
|
|
負債合計
|
|
2,365,369
|
|
2,168,368
|
|
資本
|
|
|
|
|
|
資本金
|
|
90,059
|
|
90,179
|
|
資本剰余金
|
|
-
|
|
1,966
|
|
利益剰余金
|
|
640,611
|
|
655,384
|
|
自己株式
|
|
△8,361
|
|
△2,650
|
|
その他の資本の構成要素
|
|
174,871
|
|
263,765
|
|
売却目的で保有する資産に関連する その他の包括利益
|
|
3,610
|
|
-
|
|
親会社の所有者に帰属する持分 合計
|
|
900,790
|
|
1,008,644
|
|
非支配持分
|
|
173,625
|
|
228,029
|
|
資本合計
|
|
1,074,415
|
|
1,236,673
|
|
負債及び資本合計
|
|
3,439,784
|
|
3,405,041
|
|
|
|
|
|
|
E00752
40050
住友化学株式会社
SUMITOMO CHEMICAL COMPANY, LIMITED
通期第3号参考様式 [IFRS](連結)
IFRS
true
cte
cte
2025-04-01
2026-03-31
FY
2026-03-31
2024-04-01
2025-03-31
2025-03-31
1
false
false
false
40050
2026-05-14
40050
2025-04-01
2026-03-31
40050
2025-04-01
2026-03-31
jpigp_cor:CapitalSurplusIFRSMember
40050
2025-04-01
2026-03-31
jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember
40050
2025-04-01
2026-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
40050
2025-04-01
2026-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
40050
2025-04-01
2026-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
40050
2025-04-01
2026-03-31
jpigp_cor:NonControllingInterestsIFRSMember
40050
2025-04-01
2026-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
40050
2025-04-01
2026-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
40050
2025-04-01
2026-03-31
jpcrp_cor:ReconcilingItemsMember
40050
2025-04-01
2026-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
40050
2025-04-01
2026-03-31
jpcrp_cor:ReportableSegmentsMember
40050
2025-04-01
2026-03-31
jpigp_cor:RetainedEarningsIFRSMember
40050
2025-04-01
2026-03-31
jpigp_cor:ShareCapitalIFRSMember
40050
2025-04-01
2026-03-31
jpigp_cor:TreasurySharesIFRSMember
40050
2025-04-01
2026-03-31
tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember
40050
2025-04-01
2026-03-31
tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember
40050
2025-04-01
2026-03-31
tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember
40050
2025-04-01
2026-03-31
tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember
40050
2025-04-01
2026-03-31
tse-acediffr-40050:MedicalProductsReportableSegmentMember
40050
2025-04-01
2026-03-31
tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember
40050
2026-03-31
40050
2026-03-31
jpigp_cor:CapitalSurplusIFRSMember
40050
2026-03-31
jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember
40050
2026-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
40050
2026-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
40050
2026-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
40050
2026-03-31
jpigp_cor:NonControllingInterestsIFRSMember
40050
2026-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
40050
2026-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
40050
2026-03-31
jpcrp_cor:ReconcilingItemsMember
40050
2026-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
40050
2026-03-31
jpcrp_cor:ReportableSegmentsMember
40050
2026-03-31
jpigp_cor:RetainedEarningsIFRSMember
40050
2026-03-31
jpigp_cor:ShareCapitalIFRSMember
40050
2026-03-31
jpigp_cor:TreasurySharesIFRSMember
40050
2026-03-31
tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember
40050
2026-03-31
tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember
40050
2026-03-31
tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember
40050
2026-03-31
tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember
40050
2026-03-31
tse-acediffr-40050:MedicalProductsReportableSegmentMember
40050
2026-03-31
tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember
40050
2024-04-01
2025-03-31
40050
2024-04-01
2025-03-31
jpigp_cor:CapitalSurplusIFRSMember
40050
2024-04-01
2025-03-31
jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember
40050
2024-04-01
2025-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
40050
2024-04-01
2025-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
40050
2024-04-01
2025-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
40050
2024-04-01
2025-03-31
jpigp_cor:NonControllingInterestsIFRSMember
40050
2024-04-01
2025-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
40050
2024-04-01
2025-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
40050
2024-04-01
2025-03-31
jpcrp_cor:ReconcilingItemsMember
40050
2024-04-01
2025-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
40050
2024-04-01
2025-03-31
jpcrp_cor:ReportableSegmentsMember
40050
2024-04-01
2025-03-31
jpigp_cor:RetainedEarningsIFRSMember
40050
2024-04-01
2025-03-31
jpigp_cor:ShareCapitalIFRSMember
40050
2024-04-01
2025-03-31
jpigp_cor:TreasurySharesIFRSMember
40050
2024-04-01
2025-03-31
tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember
40050
2024-04-01
2025-03-31
tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember
40050
2024-04-01
2025-03-31
tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember
40050
2024-04-01
2025-03-31
tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember
40050
2024-04-01
2025-03-31
tse-acediffr-40050:MedicalProductsReportableSegmentMember
40050
2024-04-01
2025-03-31
tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember
40050
2025-03-31
40050
2025-03-31
jpigp_cor:CapitalSurplusIFRSMember
40050
2025-03-31
jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember
40050
2025-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
40050
2025-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
40050
2025-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
40050
2025-03-31
jpigp_cor:NonControllingInterestsIFRSMember
40050
2025-03-31
jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember
40050
2025-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
40050
2025-03-31
jpcrp_cor:ReconcilingItemsMember
40050
2025-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
40050
2025-03-31
jpcrp_cor:ReportableSegmentsMember
40050
2025-03-31
jpigp_cor:RetainedEarningsIFRSMember
40050
2025-03-31
jpigp_cor:ShareCapitalIFRSMember
40050
2025-03-31
jpigp_cor:TreasurySharesIFRSMember
40050
2025-03-31
tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember
40050
2025-03-31
tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember
40050
2025-03-31
tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember
40050
2025-03-31
tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember
40050
2025-03-31
tse-acediffr-40050:MedicalProductsReportableSegmentMember
40050
2025-03-31
tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember
40050
2024-03-31
40050
2024-03-31
jpigp_cor:CapitalSurplusIFRSMember
40050
2024-03-31
jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember
40050
2024-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
40050
2024-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
40050
2024-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
40050
2024-03-31
jpigp_cor:NonControllingInterestsIFRSMember
40050
2024-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
40050
2024-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
40050
2024-03-31
jpigp_cor:RetainedEarningsIFRSMember
40050
2024-03-31
jpigp_cor:ShareCapitalIFRSMember
40050
2024-03-31
jpigp_cor:TreasurySharesIFRSMember
40050
2024-03-31
tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember
iso4217:JPY
iso4217:JPY
xbrli:shares
xbrli:pure